{"id":10132,"date":"2019-05-09T17:23:31","date_gmt":"2019-05-09T15:23:31","guid":{"rendered":"https:\/\/udic.es\/?p=10132"},"modified":"2024-02-14T19:45:25","modified_gmt":"2024-02-14T18:45:25","slug":"una-altra-diana-terapeutica-en-alzheimer","status":"publish","type":"post","link":"https:\/\/udic.es\/ca\/una-altra-diana-terapeutica-en-alzheimer\/","title":{"rendered":"Una altra diana terap\u00e8utica en Alzheimer"},"content":{"rendered":"
Iniciem un assaig de fase II \/ III amb un inhibidor de l’agregaci\u00f3 de la prote\u00efna TAU (LMTM, TRx0237), administrat per via oral, en pacients amb malaltia d’Alzheimer en fase preco\u00e7. Suposa un canvi en la diana terap\u00e8utica fins ara triada: la prote\u00efna amiloide.<\/p>\n","protected":false},"excerpt":{"rendered":"
Iniciem un assaig de fase II \/ III amb un inhibidor de l’agregaci\u00f3 de la prote\u00efna TAU (LMTM, TRx0237), administrat per via oral, en pacients amb malaltia d’Alzheimer en fase preco\u00e7. Suposa un canvi en la diana terap\u00e8utica fins ara triada: la prote\u00efna amiloide.<\/p>\n","protected":false},"author":4,"featured_media":9250,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[106],"tags":[],"class_list":["post-10132","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-alzeimer-ca"],"yoast_head":"\n